Abbott Laboratories buy BTIG Research
Start price
20.11.25
/
50%
€107.90
Target price
20.11.26
€125.82
Performance (%)
-1.91%
Price
30.12.25
€105.84
Summary
This prediction is currently active. With a performance of -1.91%, the BUY prediction for Abbott Laboratories by BTIG_Research is down slightly. This prediction currently runs until 20.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 0.208% | 0.208% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.96
16.10.25
16.10.25
€124.21
16.10.26
16.10.26
-4.61%
30.12.25
30.12.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
1.11%
30.12.25
30.12.25